Sapna Pradyuman Patel

Assistant Professor

  • 1411 Citations
  • 18 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Melanoma Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Mutation Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Adjuvant ipilimumab in high-risk Uveal melanoma

Fountain, E., Bassett, R. L., Cain, S., Posada, L., Gombos, D. S., Hwu, P., Bedikian, A. & Patel, S. P., Jan 1 2019, In : Cancers. 11, 2, 152.

Research output: Contribution to journalArticle

Open Access
Neoplasm Metastasis
Phase II Clinical Trials
Clinical Trials, Phase I

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

Abu-Sbeih, H., Ali, F. S., Qiao, W., Lu, Y., Patel, S. P., Diab, A. & Wang, Y., Jan 1 2019, (Accepted/In press) In : Cancer Immunology, Immunotherapy.

Research output: Contribution to journalArticle

Proportional Hazards Models

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W-J., Javle, M., Patel, S. P., Hu, M. I-N., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 othersKim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
1 Citation (Scopus)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Buchbinder, E. I., Dutcher, J. P., Daniels, G. A., Curti, B. D., Patel, S. P., Holtan, S. G., Miletello, G. P., Fishman, M. N., Gonzalez, R., Clark, J. I., Richart, J. M., Lao, C. D., Tykodi, S. S., Silk, A. W. & McDermott, D. F., Feb 18 2019, In : Journal for immunotherapy of cancer. 7, 1, 49.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma

Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study

Kim, K., Chung, T. H., Etzel, C. J., Kim, J., Ryu, H., Kim, D. W., Hwu, P., Hwu, W-J., Patel, S. P., Liu, M. & Kim, K. B., Dec 1 2018, In : Cancer Epidemiology. 57, p. 80-84 5 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Retrospective Studies
Immunosuppressive Agents